Timing of Galectin-1 Exposure Differentially Modulates Nipah Virus Entry and Syncytium Formation in Endothelial Cells
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nipah virus (NiV) is a deadly emerging enveloped paramyxovirus that primarily targets human endothelial cells. Endothelial cells express the innate immune effector galectin-1 that we have previously shown can bind to specific N-glycans on the NiV envelope fusion glycoprotein (F). NiV-F mediates fusion of infected endothelial cells into syncytia, resulting in endothelial disruption and hemorrhage. Galectin-1 is an endogenous carbohydrate-binding protein that binds to specific glycans on NiV-F to reduce endothelial cell fusion, an effect that may reduce pathophysiologic sequelae of NiV infection. However, galectins play multiple roles in regulating host-pathogen interactions; for example, galectins can promote attachment of HIV to T cells and macrophages and attachment of HSV-1 to keratinocytes but can also inhibit influenza entry into airway epithelial cells. Using live Nipah virus, in the present study, we demonstrate that galectin-1 can enhance NiV attachment to and infection of primary human endothelial cells by bridging glycans on the viral envelope to host cell glycoproteins. In order to exhibit an enhancing effect, galectin-1 must be present during the initial phase of virus attachment; in contrast, addition of galectin-1 postinfection results in reduced production of progeny virus and syncytium formation. Thus, galectin-1 can have dual and opposing effects on NiV infection of human endothelial cells. While various roles for galectin family members in microbial-host interactions have been described, we report opposing effects of the same galectin family member on a specific virus, with the timing of exposure during the viral life cycle determining the outcome. IMPORTANCE Nipah virus is an emerging pathogen that targets endothelial cells lining blood vessels; the high mortality rate (up to 70%) in Nipah virus infections results from destruction of these cells and resulting catastrophic hemorrhage. Host factors that promote or prevent Nipah virus infection are not well understood. Endogenous human lectins, such as galectin-1, can function as pattern recognition receptors to reduce infection and initiate immune responses; however, lectins can also be exploited by microbes to enhance infection of host cells. We found that galectin-1, which is made by inflamed endothelial cells, can both promote Nipah virus infection of endothelial cells by “bridging” the virus to the cell, as well as reduce production of progeny virus and reduce endothelial cell fusion and damage, depending on timing of galectin-1 exposure. This is the first report of spatiotemporal opposing effects of a host lectin for a virus in one type of host cell.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/bti770 · Cited by 6,988
Nipah Virus Encephalitis Reemergence, Bangladesh
Hsu, V. P., Hossain, M. J., Parashar, U. D., Ali, M. M., Ksiazek, T. G., Kuzmin, I., Niezgoda, M., Rupprecht, C., Bresee, J., & Breiman, R. F. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1012.040701 · Cited by 618 · cited 1×
“fatality rates ranging from 40 to 100% in humans (1, 2).”
BackgroundEphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570 · cited 2×
“that express the entry receptor ephrinB2 (4).”
BackgroundSelf-citationGalectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death
Stillman, B. N., Hsu, D. K., Pang, M., Brewer, C. F., Johnson, P., Liu, F.-T., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.778 · Cited by 507
Self-citationGalectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Thijssen, V. L. J. L., Postel, R., Brandwijk, R. J. M. G. E., Dings, R. P. M., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603883103 · Cited by 497 · cited 2×
“Innate immune mediators such as galectins have many functions, including triggering endothelial activation, inducing cytokine production and release, promoting leukocyte infiltration of infected tissues, and mediating pathogen clearance (10, 14, 16, 35, 36).”
BackgroundSelf-citationStructure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation
Yin, H.-S., Wen, X., Paterson, R. G., Lamb, R. A., & Jardetzky, T. S. (2006) · Nature · doi:10.1038/nature04322 · Cited by 418 · cited 1×
“(A) A model of the glycosylated NiV-F ectodomain in the prefusion state was created with the Swiss-Model server (52) using the structure of the parainfluenza virus 5 F protein in the metastable, prefusion conformation (PDB accession number 2B9B) (53) as a template.”
MethodPace, K. E., Lee, C., Stewart, P. L., & Baum, L. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3801 · Cited by 351
Self-citationKifunensine, a potent inhibitor of the glycoprotein processing mannosidase I.
Elbein, A. D., Tropea, J. E., Mitchell, M., & Kaushal, G. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55439-9 · Cited by 331
Innate immune lectins kill bacteria expressing blood group antigen
Stowell, S. R., Arthur, C. M., Dias-Baruffi, M., Rodrigues, L. C., Gourdine, J.-P., Heimburg-Molinaro, J., Ju, T., Molinaro, R. J., Rivera-Marrero, C., Xia, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2103 · Cited by 324 · cited 1×
“For example, galectin-4 and galectin-8 bind to and directly kill human blood-group B expressing Escherichia coli (15), and galectin-3 binds to and directly kills Candida albicans (16) in the absence of immunoglobulin or complement.”
BackgroundTwo Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus
Negrete, O. A., Wolf, M. C., Aguilar, H. C., Enterlein, S., Wang, W., Mühlberger, E., Su, S. V., Bertolotti-Ciarlet, A., Flick, R., & Lee, B. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020007 · Cited by 322 · cited 1×
“ment protein NiV-G binds to ephrinB2 or ephrinB3 (5) on the”
BackgroundSelf-citation
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Galectin-1 can have dual and opposing effects on virus infection of human endothelial cells (780).”
BackgroundExploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Self-citationGlobal aspects of viral glycosylation
Bagdonaite, I., & Wandall, H. H. (2018) · Glycobiology · doi:10.1093/glycob/cwy021 · Cited by 234
“…Paramyxoviridae Henipavirus (−)ssRNA Bowden et al. (2008) Stone et al. (2016) BradelTretheway et al. (2015); Stone et al. (2016) Aguilar et al. (2006); Garner et al. (2015) Stone et al. (2016) MeV Measles virus Paramyxoviridae Morbillivirus (−)ssRNA Hu et al. (1995) Hu et al. (1995) HRSV Human…”
BackgroundInfluentialGalectins and Immune Responses—Just How Do They Do Those Things They Do?
Thiemann, S., & Baum, L. G. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055402 · Cited by 230
“Another relevant example of this type of spatial constraint regulating galectin binding is our finding that galectin-1 binding to trimeric fusion glycoproteins on an enveloped virus likely resulted in cross-linking of adjacent trimers rather than intratrimer binding (35).”
BackgroundSelf-citationThe role of galectins in virus infection - A systemic literature review
Wang, W., Lin, C.-Y., Chang, M. R., Urbina, A. N., Assavalapsakul, W., Thitithanyanont, A., Chen, Y., Liu, F., & Wang, S. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.09.005 · Cited by 136
The Role of Collectins and Galectins in Lung Innate Immune Defense
Casals, C., Campanero‐Rhodes, M. A., García-Fojeda, B., & Solís, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01998 · Cited by 83
Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities
Yu, X., Qian, J., Ding, L., Yin, S., Zhou, L., & Zheng, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076501 · Cited by 77
“That is, pre-infective galectin-1 promotes NiV infection; in contrast, post-infective galectin-1 impairs syncytium formation as well as virus production, and this inhibition is unique to the Paramyxoviridae family [43,47].”
BackgroundFunctions of galectins as ‘self/non-self’-recognition and effector factors
Vasta, G. R., Feng, C., González‐Montalbán, N., Mancini, J., Yang, L., Abernathy, K., Frost, F. G., & Palm, C. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx046 · Cited by 81
“initial phase of virus attachment, it can also enhance NiV adhesion to and infection of the endothelial cell surface by bridging glycans on the viral envelope to host cell glycoproteins (Garner et al. 2015).”
BackgroundLo, M. K., Spengler, J. R., Krumpe, L. R. H., Welch, S. R., Chattopadhyay, A., Harmon, J. R., Coleman-McCray, J. D., Scholte, F. E. M., Hotard, A. L., Fuqua, J. L., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz630 · Cited by 63
“Inhibitors of NiV entry and spread generally target protein interactions involved in receptor binding or membrane fusion processes [5] [6] [7] [8] [9] [10] , but the glycosylation of NiV glycoproteins presents another viable target for therapeutic development [11] [12] [13] .”
Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus
Lee, B., Pernet, O., Ahmed, A. A., Zeltina, A., Beaty, S. M., & Bowden, T. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501690112 · Cited by 76
“NiV and GhV pseudotyped particles (NiVpp and GhVpp) were produced as described (12, 19, 65).”
MethodSelf-citationLazar, M. N., Mancini, J., Feng, C., González‐Montalbán, N., Ravindran, C., Jackson, S. S., Heras-Sánchez, A. D. L., Giomarelli, B., Ahmed, H., Haslam, S. M., et al. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.09.007 · Cited by 61
Park, A., Yun, T., Vigant, F., Pernet, O., Won, S. T., Dawes, B. E., Wojciech, B., Freiberg, A. N., & Lee, B. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005659 · Cited by 45
Self-citationGlycosylation-dependent galectin–receptor interactions promote Chlamydia trachomatis infection
Lujan, A. L., Croci, D. O., Tudela, J. G., Losinno, A. D., Cagnoni, A. J., Mariño, K. V., Damiani, M. T., & Rabinovich, G. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802188115 · Cited by 51
“However, Gal1 favors Nipah virus attachment to endothelial cells but inhibits the fusion of its envelope glycoproteins with target cells (33).”
BackgroundWienke, J., Pachman, L. M., Morgan, G. A., Yeo, J. G., Amoruso, M. C., Hans, V., Kamphuis, S. S. M., Hoppenreijs, E. P. A. H., Armbrust, W., van den Berg, J. M., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41236 · Cited by 43
Utilization of Galectins by Pathogens for Infection
Ayona, D., Fournier, P., Henrissat, B., & Desnues, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01877 · Cited by 45
“It has also been shown that Gal-1 addition before infection increases syncytia formation, but Gal-1 addition after the infection reduces the progeny virus production and syncytia formation (79).”
BackgroundInfluentialGalectins in Host–Pathogen Interactions: Structural, Functional and Evolutionary Aspects
Vasta, G. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1580-4_7 · Cited by 48
Innate immunity against molecular mimicry: Examining galectin‐mediated antimicrobial activity
Arthur, C. M., Patel, S. R., Mener, A., Kamili, N. A., Fasano, R. M., Meyer, E., Winkler, A. M., Sola-Visner, M. C., Josephson, C. D., & Stowell, S. R. (2015) · BioEssays · doi:10.1002/bies.201500055 · Cited by 37
“The timing of galectin exposure in the infectious process may in part dictate the outcome of these galectin-mediated events [129].”
BackgroundDifferential Features of Fusion Activation within the Paramyxoviridae
Azarm, K. D., & Lee, B. (2020) · Viruses · doi:10.3390/v12020161 · Cited by 34
“In contrast, removal of N-glycans from the globular head of NiV-RBP results in hyperfusogenic phenotypes, suggesting the presence of N-glycans in the wild-type virus could impair cell-cell fusion levels in order to reduce syncytia formation and cell death, thus allowing maximum host survival and viral spread.”
BackgroundInfluentialSelf-citationStone, J. A., Nicola, A. V., Baum, L. G., & Aguilar, H. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005445 · Cited by 32
Self-citationGal power: the diverse roles of galectins in regulating viral infections
Machala, E. A., McSharry, B. P., Rouse, B. T., Abendroth, A., & Slobedman, B. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001208 · Cited by 33
Vasta, G. R., & Wang, J. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103721 · Cited by 36
Sun, J., Han, Z., Qi, T., Zhao, R., & Liu, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772897 · Cited by 30
“Viral infection can modulate the expression and function of galectin-1, and the complex interplay between galectin-1 and virus may ultimately determine the outcome of infection (7, 8, 19, 24, 29).”
BackgroundInfluentialAddicted to sugar: roles of glycans in the orderMononegavirales
Ortega, V., Stone, J. A., Contreras, E. M., Iorio, R. M., & Aguilar, H. C. (2018) · Glycobiology · doi:10.1093/glycob/cwy053 · Cited by 32
“2010 (Garner et al.”
Self-citationGalectin-1 Ameliorates Influenza A H1N1pdm09 Virus-Induced Acute Lung Injury
Bao, J., Wang, X., Liu, S., Zou, Q., Zheng, S., Yu, F., & Chen, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01293 · Cited by 19
Human galectin-1 and galectin-3 promote Tropheryma whipplei infection
Ayona, D., Zarza, S. M., Landemarre, L., Roubinet, B., Decloquement, P., Raoult, D., Fournier, P., & Desnues, B. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1884515 · Cited by 16
“In contrast, addition of Gal-1 inhibits the internalization of Dengue virus and Nipah Virus.(29,45,46) We demonstrated that both Gal-1 and Gal-3 enhance T.”
BackgroundToudic, C., Vargas, A., Xiao, Y., St‐Pierre, G., Bannert, N., Lafond, J., Rassart, É., Sato, S., & Barbeau, B. (2019) · The FASEB Journal · doi:10.1096/fj.201900107r · Cited by 15
“The same results have been observed for both HIV-1 and the Nipah virus, in which Gal-1 increased the binding of viral particles to target cells (55, 57, 79).”
ResultOncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells
Ferreira, T., Kulkarni, A. S., Bretscher, C., Nazarov, P. V., Hossain, J. A., Ystaas, L., Miletić, H., Röth, R., Niesler, B., & Marchini, A. (2022) · Viruses · doi:10.3390/v14051018 · Cited by 15
“During Nipah virus (NiV) infection, Gal-1 enhances virus cell attachment to primary human endothelial cells [49].”
BackgroundBlaurock, C., Pfaff, F., Scheibner, D., Hoffmann, B., Fusaro, A., Monne, I., Mettenleiter, T. C., Breithaupt, A., & Abdelwhab, E. M. (2022) · Journal of Virology · doi:10.1128/jvi.00994-22 · Cited by 14
Molecular determinants of cross-species transmission in emerging viral infections
Wickenhagen, A., van Tol, S., & Munster, V. J. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-23 · Cited by 19
“Differential host expression of galectin-1 might then influence pathogenesis to henipaviruses that bind ephrin B2 through inhibiting syncytia formation (147, 148).”
Campanero‐Rhodes, M. A., Kalograiaki, I., Euba, B., Llobet, E., Ardá, A., Jiménez‐Barbero, J., Garmendia, J., & Solís, D. (2021) · Biomolecules · doi:10.3390/biom11040595 · Cited by 12
Sandamalika, W. M. G., & Lee, J. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.09.017 · Cited by 11
Haas, G. D., Kowdle, S., Schmitz, K. S., Azarm, K. D., Johnson, K. N., Klain, W. R., Freiberg, A. N., Cox, R. M., Plemper, R. K., & Lee, B. (2024) · Journal of Virology · doi:10.1128/jvi.00806-24 · Cited by 9
Self-citationFeng, C., Cross, A. S., & Vasta, G. R. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.02.011 · Cited by 7
Iqbal, M., Feng, C., Zong, G., Wang, L., & Vasta, G. R. (2024) · Glycobiology · doi:10.1093/glycob/cwae093 · Cited by 6
The Multifaceted Roles of Galectins in Host–Virus Interactions: A Comprehensive Overview
Tung, Y.-W., Yang, Z., Huang, J., Hsu, Y.-T., Tsui, C.-I., Hemdan, M. S., Tadikamalla, S., Baua, A. D., Assavalapsakul, W., Thitithanyanont, A., et al. (2025) · Glycobiology · doi:10.1093/glycob/cwaf026 · Cited by 4
De novo rescue of new henipaviruses under BSL-4 conditions – From sequence to pathogen
Haas, G. D., & Lee, B. (2025) · Advances in virus research · doi:10.1016/bs.aivir.2025.03.004 · Cited by 2
Self-citationHaas, G. D., Escaffre, O., Reis, R. A., Juelich, T. L., Smith, J. K., Zhang, L., Kalveram, B., Guzmán-Solís, A. A., Vyshenska, D., Klain, W. R., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117074 · Cited by 2
Self-citationAnderson, D. E., & Wang, L. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch40 · Cited by 2
The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins
Liu, Y., & Ma, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04153-1_26 · Cited by 1
Repurposing Clinical Candidates for Nipah and Hendra Viruses
Lane, T. R., Escaffre, O., Zhang, L., Smith, J. K., Juelich, T. L., Freiberg, A. N., & Ekins, S. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00206 · Cited by 1
Self-citationPlacenta and infections : Coxiella burnetii and SARS-CoV-2
Zarza, S. M. (2022) · theses.fr (ABES) · doi:10.70675/423df3fez00c0z48acz9a6bz7cf26b598c75
Abernathy, K., Wang, S. W., Feng, C., Mancini, J., Zong, G., González‐Montalbán, N., Wang, L., & Vasta, G. R. (2026) · Biomolecules · doi:10.3390/biom16060882
Metadata
- Authors
- Garner, O. B., Yun, T., Pernet, O., Aguilar, H. C., Park, A., Bowden, T. A., Freiberg, A. N., Lee, B., & Baum, L. G.
- Affiliations
- University of California, Los Angeles (US)
- The University of Texas Medical Branch at Galveston (US)
- Washington State University (US)
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2015-03
- Volume
- 89
- Issue
- 5
- Pages
- 2520-2529
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC4325760
- OpenAlex
- W2155935053
- Cited by
- 43
- References
- 57
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 3
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Wellcome Trust (090532)
- Medical Research Council (MR/L009528/1)
- National Heart, Lung, and Blood Institute (T32 HL-69766, T32HL069766)
- National Institute of Allergy and Infectious Diseases (R01AI109022, R01AI060694, U54AI057156, UC7AI094660)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Keywords
- Nipah virus, galectin-1, endothelial cells, syncytium formation, viral entry, N-glycans, host-pathogen interaction, lectins, pattern recognition receptors, hemorrhage, viral attachment, hemorrhagic fever, endothelial disruption
- MeSH terms
- Cells, Cultured, Humans, Giant Cells, Galectin 1, Endothelial Cells, Nipah Virus, Virus Internalization, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.